Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Heart Transplant Infection: early-phase trial registry
2 of 4 indexed Heart Transplant Infection trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Heart Transplant Infection: 4 US clinical trials tracked, 2 recruiting.
Heart Transplant Infection is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Columbia University, running 1 of these trials.
Enrollment posture brief
Registry condition heart-transplant-infection
OPEN 2 | RECR 50% | LATE 1 | EARLY 2 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Heart Transplant Infection lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Heart Transplant Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Heart Transplant Infection is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant
Columbia University
NCT07079735
Levothyroxine Supplementation for Heart Transplant Recipients
University of California, San Francisco
NCT06428097
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
Mayo Clinic
NCT04508907
CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients
Vanderbilt University Medical Center
NCT03924219
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Heart Transplant Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Heart Transplant Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Heart Transplant Infection page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Heart Transplant Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Columbia University sponsors the most Heart Transplant Infection trials on record, review their full trial history before evaluating a specific study. See Columbia University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Heart Transplant Infection condition card totals 4 registered trials; most-linked intervention Mavyret; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.